Literature DB >> 26796376

Three-Dimensional Computed Tomographic Angiography Study of the Interperforator Flow of the Lower Leg.

Yoo Joon Sur1,2, Mohamed Morsy1,2, Anita T Mohan1,2, Lin Zhu1,2, Gregory J Michalak1,2, Nirusha Lachman1,2, Alexis T Laungani1,2, Nick van Alphen1,2, Michel Saint-Cyr1,2.   

Abstract

BACKGROUND: The area perfused by a single perforator depends on its perforasome and its unique interperforator flow pattern. The purpose of this study was to clarify the interperforator flow patterns of the peroneal and posterior tibial artery perforators using three-dimensional computed tomographic angiography.
METHODS: Thirteen whole-leg skin flaps were harvested in the subfascial plane from fresh cadavers. Peroneal, posterior tibial, anterior tibial, and sural artery perforators with a diameter greater than 0.5 mm were documented. Three-dimensional computed tomographic angiography with an injection of iodinated contrast medium into the peroneal or posterior tibial artery perforator was used to investigate the percentages of the area and the perforators that were perfused.
RESULTS: The mean percentage of the total area perfused was as follows: peroneal artery perforator, 42.0 percent; posterior tibial artery perforator, 38.0 percent (p = 0.084). The mean percentage of the total perforators perfused was as follows: peroneal artery perforator, 55.0 percent; posterior tibial artery perforator, 44.2 percent (p = 0.004). Although the mean percentages of same-source artery perforators perfused by a peroneal artery perforator (73.6 percent) and by a posterior tibial artery perforator (77.2 percent) did not differ (p = 0.513), the mean percentages of other-source artery perforators perfused by a peroneal artery perforator (49.9 percent) and by a posterior tibial artery perforator (32.3 percent) were significantly different (p < 0.001).
CONCLUSIONS: This study demonstrated that a single peroneal or posterior tibial artery perforator perfused approximately 40 percent of the whole leg surface and that peroneal and posterior tibial artery perforators had different interperforator flow patterns. The results of this study may improve preoperative planning for pedicled perforator flap surgery. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, V.

Entities:  

Mesh:

Year:  2016        PMID: 26796376     DOI: 10.1097/PRS.0000000000002111

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  6 in total

1.  [Application of free peroneal artery chimeric perforator flap in repairing the defect after advanced local lesions resection in parotid gland carcinoma].

Authors:  Dongkun Yang; Jiancheng Li; Zhigang Wu; Kai Hu; Yun Guo; Yue Sun
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-01-15

2.  Increasing Perfusion Pressure Does Not Distend Perforators or Anastomoses but Reveals Arteriovenous Shuntings.

Authors:  Adam C Gascoigne; G Ian Taylor; Russell J Corlett; Chris Briggs; Mark W Ashton
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-06-24

Review 3.  Advances in imaging technologies for planning breast reconstruction.

Authors:  Anita T Mohan; Michel Saint-Cyr
Journal:  Gland Surg       Date:  2016-04

4.  [Clinical application of digital technology in repairing of heel wound with peroneal artery perforator propeller flap].

Authors:  Wanqiu Zhao; Yongqing Xu; Xiaoqing He; Haotian Luo; Yujian Xu
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-03-15

5.  Interperforator Flow Pattern and Clinical Application of Distal Extended Peroneal Artery Perforator Flaps.

Authors:  Chengliang Deng; Bihua Wu; Zairong Wei; Hai Li; Tianhua Zhang; Dali Wang
Journal:  Ann Plast Surg       Date:  2018-05       Impact factor: 1.539

6.  Double-pedicle propeller flap for reconstruction of the foot and ankle: anatomical study and clinical applications.

Authors:  Jianxiong Zheng; Hua Liao; Jie Li; Lingjian Zhuo; Gaohong Ren; Ping Zhang; Jijie Hu
Journal:  J Int Med Res       Date:  2019-08-05       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.